NCT03034005View on ClinicalTrials.gov

The RECONSTRUCT Study - Reconstructing Disease Mechanisms in Asthma

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 27, 2017

Primary Completion Date

February 28, 2019

Study Completion Date

February 28, 2019

Conditions
Asthma
Interventions
DRUG

Budesonide

1600 ug inhaled daily for 6 weeks

Trial Locations (1)

2400

Lungemedicinsk forskningsenhed, Bispebjerg Hospital, Copenhagen

All Listed Sponsors
lead

Bispebjerg Hospital

OTHER

NCT03034005 - The RECONSTRUCT Study - Reconstructing Disease Mechanisms in Asthma | Biotech Hunter | Biotech Hunter